GAO: FDA fails to track drugmakers conducting postmarket studies

10/26/2009 | · Washington Post, The

The Government Accountability Office released a report showing the FDA has been unable to track the progress of many of the postmarket studies it required from drugmakers between 1992 and 2008. Dr. Joshua Sharfstein, deputy FDA commissioner, said that since 2007 the FDA has "completely overhauled" its postmarket surveillance processes, and it continues to work to fix past problems.

View Full Article in: · Washington Post, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice President - Government Products
Health Alliance Plan
Detroit, MI
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Meridian Health Plan
Detroit, MI
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
President/Chief Executive Officer
Winston-Salem, NC